S-1/A 1 lb120_s1a.htm FORM S-1/A

 

As filed with the Securities and Exchange Commission on May 9, 2023.

 

No. 333-266613

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

AMENDMENT NO. 16 TO

FORM S-1

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

 

MDNA LIFE SCIENCES INC.

(Exact name of registrant as specified in its charter)

 

Delaware 8731 30-0845609

(State or other jurisdiction of
incorporation or organization)

 (Primary Standard Industrial
Classification Code Number)

(I.R.S. Employer

Identification No.)

 

2054 Vista Parkway, Suite 400
West Palm Beach, FL 33411

(844) 321-6362

 

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Christopher C. Mitton

Chief Executive Officer

MDNA Life Sciences Inc.
2054 Vista Parkway, Suite 400

West Palm Beach, FL 33411

(844) 321-6362

 

(Name, address, including zip code, and telephone number, including area code, of agent for service)

 

Copies to:

 

Joseph M. Lucosky, Esq.

Soyoung Lee, Esq. 

Lucosky Brookman LLP

101 Wood Avenue South, 5th Floor

Iselin, New Jersey 08830

Telephone: (732) 395-4400

Fax: (732) 395-4401

David R. Crandall, Esq.

Brandon Kinnard, Esq.

Hogan Lovells US LLP

1601 Wewatta St., Suite 900

Denver, Colorado 80202

Telephone: (303) 899-7300

Fax: (303) 899-7333

  

Approximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this registration statement.

 

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box: x

 

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ¨

 

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ¨

 

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ¨ Accelerated filer ¨
Non-accelerated filer x Smaller reporting company x
    Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ¨

 

The Registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment that specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act, or until the registration statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said section 8(a), may determine.  

 

 

 

   

 

 

EXPLANATORY NOTE

 

This Amendment No. 16 to the Registration Statement on Form S-1 (File No. 333-266613) is filed solely to file certain exhibits. This Amendment No. 16 does not modify any provision of the preliminary prospectus contained in Part I. Accordingly, the preliminary prospectus has been omitted.

 

 

 

 

PART II

 

INFORMATION NOT REQUIRED IN PROSPECTUS

 

Item 13. Other Expenses of Issuance and Distribution.

 

The following table indicates the expenses to be incurred in connection with the offering described in this registration statement, other than underwriting discounts and commissions, all of which will be paid by us. All amounts are estimated except the Securities and Exchange Commission registration fee and the Financial Industry Regulatory Authority, Inc., or FINRA filing. 

 

    Amount to 
be paid		  
SEC registration fee   $

6,600

  
FINRA filing fee   $ 5,675  
Nasdaq initial listing fee   $  5,000  
Transfer agent and registrar fees   $ 1,000  
Accounting fees and expenses   $ 75,000  
Legal fees and expenses   $ 375,000  
Printing and engraving expenses   $ 2,000  
Miscellaneous   $ 3,000  
Total   $

473,275

  

 

Item 14. Indemnification of Directors and Officers.

 

Section 102 of the General Corporation Law of the State of Delaware (the “DGCL”) permits a corporation to eliminate the personal liability of directors of a corporation to the corporation or its shareholders for monetary damages for a breach of fiduciary duty as a director, except where the director breached his duty of loyalty, failed to act in good faith, engaged in intentional misconduct or knowingly violated a law, authorized the payment of a dividend or approved a stock repurchase in violation of Delaware corporate law or obtained an improper personal benefit. Our certificate of incorporation provides that none of our directors shall be personally liable to us or our shareholders for monetary damages for any breach of fiduciary duty as a director, notwithstanding any provision of law imposing such liability, except to the extent that the DGCL prohibits the elimination or limitation of liability of directors for breaches of fiduciary duty.

 

Section 145 of the DGCL provides that a corporation has the power to indemnify a director, officer, employee, agent of the corporation or a person serving at the request of the corporation for another corporation, partnership, joint venture, trust or other enterprise in related capacities against expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by the person in connection with an action, suit or proceeding to which he was or is a party or is threatened to be made a party to any threatened, ending or completed action, suit or proceeding by reason of such position, if such person acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of the corporation, and, in any criminal action or proceeding, had no reasonable cause to believe his conduct was unlawful, except that, in the case of actions brought by or in the right of the corporation, no indemnification shall be made with respect to any claim, issue or matter as to which such person shall have been adjudged to be liable to the corporation unless and only to the extent that the Court of Chancery or other adjudicating court determines that, despite the adjudication of liability.

 

Our Certificate of Incorporation and our Bylaws provide for indemnification of our directors and officers. Our Bylaws provide that we will indemnify any person who was or is a party or threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative (other than an action by or in the right of the corporation) by reason of the fact that such person is or was a legal representative, director, officer or employee or agent of the Company, against expenses (including attorney’s fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with such action, suit or proceeding if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the Company, and with respect to any criminal action or proceeding, had no reasonable cause to believe such person’s conduct was unlawful. The termination of any action, suit or proceeding by judgment, order, settlement, conviction, or upon a plea of nolo contendere or its equivalent will not, without more, create a presumption that the person did not act in good faith and in a manner which such person reasonably believed to be in or not opposed to the best interest of the corporation, and, with respect to any criminal action or proceeding, had reasonable cause to believe that his conduct was unlawful.

 

 II-1 

 

  

Item 15. Recent Sales of Unregistered Securities.

 

The following sets forth information regarding all unregistered securities sold by us in the last three years in transactions that were exempt from the requirements of the Securities Act as provided for by Section 4(a)(2) thereof for transactions not involving a public offering, to the extent an exemption from such registration was required or exempt from registration either under Rule 701 promulgated under the Securities Act, in that the transactions were under compensatory benefit plans and contracts relating to compensation.

 

No underwriters were involved in any of the foregoing issuances of securities listed in (a), (b) or (c) below.

 

  (a) Convertible Notes

 

Note Holder  Issue Date  Note Denomination  Consideration
Received /
Issue Amount		   Maturity Date  Interest Rate   Default
Interest
Rate		   Conversion
Hobart Ltd  11/04/19  USD   68,936   4/30/23   8%   18%  0.08  Class A Common per $1.00
Smart, Harald  11/04/19  USD   110,298   4/30/23   8%   18%  0.08  Class A Common per $1.00
Turner, James Graham  11/07/19  USD   20,000   4/30/23   8%   18%  0.08  Class A Common per $1.00
Poulter, Marica  11/12/19  USD   50,000   4/30/23   8%   18%  0.08  Class A Common per $1.00
Clydagh Ltd  11/15/19  USD   106,383   4/30/23   8%   18%  0.08  Class A Common per $1.00
Hill, Christopher  01/11/20  USD   5,000   4/30/23   8%   18%  0.08  Class A Common per $1.00

  

 II-2 

 

 

Hobart Ltd       03/27/20   GBP     17,500     4/30/23     8 %     18 %   0.19 Class A Common per £1.00
Pankhurst, Julie       03/30/20   USD     17,500     4/30/23     8 %     18 %   0.15 Class A Common per $1.00
Pankurst, Stephen       03/30/20   USD     17,500     4/30/23     8 %     18 %   0.15 Class A Common per $1.00
Ward, Tim       03/30/20   USD     33,000     4/30/23     8 %     18 %   0.15 Class A Common per $1.00
Smart, Harald       04/01/20   USD     10,000     4/30/23     8 %     18 %   0.15 Class A Common per $1.00
Clydagh Ltd       04/06/20   USD     212,766     4/30/23     8 %     18 %   0.15 Class A Common per $1.00
Elliott, Michael       04/10/20   GBP     10,638     4/30/23     8 %     18 %   0.19 Class A Common per £1.00
Gerald M Casey Trust UAD 05/03/2000       04/22/20   USD     10,000     4/30/23     8 %     18 %   0.15 Class A Common per $1.00
Gelbfish, Gary       05/14/20   USD     100,000     4/30/23     8 %     18 %   0.15 Class A Common per $1.00
Lefkowitz ,Steven       05/14/20   USD     30,000     4/30/23     8 %     18 %   0.15 Class A Common per $1.00
Turner, James Graham       05/18/20   USD     20,000     4/30/23     8 %     18 %   0.15 Class A Common per $1.00
Crandall, Keith       05/22/20   USD     10,638     4/30/23     8 %     18 %   0.15 Class A Common per $1.00
Poulter, Donald       05/29/20   USD     10,638     4/30/23     8 %     18 %   0.08 Class A Common per $1.00
Mitton, Christopher       05/31/20   USD     10,638     4/30/23     8 %     18 %   0.08 Class A Common per $1.00
Turner, James       10/12/20   USD     10,000     4/30/23     10 %     18 %   206 Common Stock for Every USD $1,000
1204742 Ontario Limited       10/17/20   CAD     100,000     4/30/23     10 %     18 %   206 Common Stock for every $CAD 1,350
Elliott, Michael       10/17/20   GBP     10,000     4/30/23     10 %     18 %   206 Common Stock for every GBP£ 769.23
Hobart Ltd       10/17/20   GBP     57,692     4/30/23     10 %     18 %   206 Common Stock for every GBP£ 769.23
Harry Smart       10/17/20   GBP     57,692     4/30/23     10 %     18 %   206 Common Stock for every GBP£ 769.23

  

 II-3 

 

 

Clydagh       10/17/20   USD     100,000     4/30/23     10 %     18 %   206 Common Stock for Every USD $1,000
Money Market Investment Club Toldeo       10/17/20   USD     10,000     4/30/23     10 %     18 %   206 Common Stock for Every USD $1,000
Pankhurst, Julie       10/17/20   USD     25,000     4/30/23     10 %     18 %   206 Common Stock for Every USD $1,000
Pankhurst, Stephen       10/17/20   USD     25,000     4/30/23     10 %     18 %   206 Common Stock for Every USD $1,000
Ward, Tim       10/17/20   USD     50,000     4/30/23     10 %     18 %   206 Common Stock for Every USD $1,000
Andrew Harbottle   Deferred Salary   11/01/20   GBP     36,517     4/30/23     8 %     18 %   82 shares for each 400 (GBP)
Robert Poulter   Deferred Salary   12/01/20   USD     205,078     4/30/23     8 %     18 %   82 shares for each $550
Christopher Mitton   Deferred Salary   12/01/20   USD     218,750     4/30/23     8 %     18 %   82 shares for each $550
Smart, Harry       09/30/21   USD     159,682     4/30/23     12 %     15 %   $6.68 per share but goes to 75% of the offering price in an IPO if the IPO occurs before maturity
Thunder Bay Financial       09/30/21   USD     209,700     4/30/23     12 %     15 %   $6.68 per share but goes to 75% of the offering price in an IPO if the IPO occurs before maturity
Jones, Tyler       09/30/21   USD     100,000     4/30/23     12 %     15 %   $6.68 per share but goes to 75% of the offering price in an IPO if the IPO occurs before maturity
Lefkowitz, Steven       09/30/21   USD     100,000     4/30/23     12 %     15 %   $6.68 per share but goes to 75% of the offering price in an IPO if the IPO occurs before maturity
Goh, Kim       09/30/21   USD     100,000     4/30/23     12 %     15 %   $6.68 per share but goes to 75% of the offering price in an IPO if the IPO occurs before maturity

 

 II-4 

 

 

Gelbfish, Gary       09/30/21   USD     400,000     4/30/23     12 %     15 %   $6.68 per share but goes to 75% of the offering price in an IPO if the IPO occurs before maturity
Deyoe, Lane       10/20/21   USD     300,000     4/30/23     12 %     15 %   $6.68 per share but goes to 75% of the offering price in an IPO if the IPO occurs before maturity
Robert Poulter   Deferred Salary   11/01/21   USD     215,531     4/30/23     8 %     18 %   0.15 Class A Common per $1.00
Andrew Harbottle   Deferred Salary   11/01/21   GBP     41,733     4/30/23     8 %     18 %   82 shares for each 400 (GBP)
Christopher Mitton   Deferred Salary   11/01/21   USD     229,900     4/30/23     8 %     18 %   0.15 Class A Common per $1.00
Jennifer Creed   Deferred Salary   11/01/21   USD     275,188     4/30/23     8 %     18 %   0.15 Class A Common per $1.00
Boral, David       07/29/22   USD     125,000     1/28/2024     12 %     15 %   $6.68 per share but goes to 75% of the offering price in an IPO if the IPO occurs before maturity
Rallo, Joseph       07/29/22   USD     125,000     1/28/2024     12 %     15 %   $6.68 per share but goes to 75% of the offering price in an IPO if the IPO occurs before maturity
Pankhurst, Steven       07/29/22   USD     25,000     1/28/2024     12 %     15 %   $6.68 per share but goes to 75% of the offering price in an IPO if the IPO occurs before maturity
Pankhurst, Julie       07/29/22   USD     25,000     1/28/2024     12 %     15 %   $6.68 per share but goes to 75% of the offering price in an IPO if the IPO occurs before maturity
                                             
Tim Ward       08/10/22   GBP     25,000     01/28/24     12 %     15 %   $6.68 per share but goes to 75% of the offering price in an IPO if the IPO occurs before maturity
Tim Ward       11/20/22   USD     14,357     4/30/23     12 %     15 %   $6.68 per share but goes to 75% of the offering price in an IPO if the IPO occurs before maturity
Stephen Pankhurst       12/06/22   USD     26,316     6/01/23     12 %     15 %   $6.68 per share but goes to 75% of the offering price in an IPO if the IPO occurs before maturity
Patrick Galatowitsch       12/30/22   USD     100,000     6/01/23     12 %     15 %   $6.68 per share but goes to 75% of the offering price in an IPO if the IPO occurs before maturity
Camshaft Capital Fund LP       2/10/23   USD     300,000     8/01/23     12 %     15 %   75% of the offering price in an IPO if the IPO occurs before maturity

 

The total amount of convertible notes issued by the Company for the past three years and as of September 30, 2022 is $6,089,162.

  

 II-5 

 

 

(b)Warrant issuances in connection with the convertible notes listed above:

 

Warrant Holder   Date
Issued		   Number
Issued		     Exercise
Price		     Expiration
Date
Turner, James Graham   11/7/2019                      824       15.42     11/7/2023
Hobart Ltd   11/4/2019                      568       12.14     11/4/2023
Hobart Ltd   11/4/2019                  2,839       15.42     11/4/2023
Smart, Harald Ernest   11/4/2019                      909       12.14     11/4/2023
Smart, Harald Ernest   11/4/2019                  4,543       15.42     11/4/2023
Hill, Christopher   11/4/2019                        41       12.14     11/4/2023
Hill, Christopher   11/4/2019                      206       15.42     11/4/2023
Clydagh Ltd   11/15/2019                      876       12.14     11/15/2023
Clydagh Ltd   11/15/2019                  4,381       15.42     11/15/2023
Poulter, Marica   11/12/2019                      412       12.14     11/12/2023
Poulter, Marica   11/12/2019                  2,059       15.42     11/12/2023
Thunder Bay Financial ,LLC   2/3/2020                11,862       12.14     2/3/2025
Hobart Ltd   3/27/2020                      177       12.14     3/27/2024
Hobart Ltd   3/27/2020                      883       15.42     3/27/2024
Pankhurst, Stephen   3/30/2020                      144       12.14     3/30/2024
Pankhurst, Stephen   3/30/2020                      721       15.42     3/30/2024
Pankhurst, Julie   3/30/2020                      144       12.14     3/30/2024
Pankhurst, Julie   3/30/2020                      721       15.42     3/30/2024
Ward, Tim   3/30/2020                      272       12.14     3/30/2024
Ward, Tim   3/30/2020                      136       15.42     3/30/2024
Smart, Harald Ernest   4/1/2020                        82       12.14     4/1/2024
Smart, Harald Ernest   4/1/2020                      412       15.42     4/1/2024
Smart, Harald Ernest   4/1/2020                  8,237       12.14     4/1/2024
Clydagh Ltd   4/6/2020                  1,753       12.14     4/6/2024
Clydagh Ltd   4/6/2020                  8,763       15.42     4/6/2024
Elliott, Michael   4/9/2020                      109       12.14     4/9/2024
Elliott, Michael   4/9/2020                      545       15.42     4/9/2024
Gerald M Casey Trust UAD 05/03/2000   4/22/2020                        82       12.14     4/22/2024
Gerald M Casey Trust UAD 05/03/2000   4/22/2020                      412       15.42     4/22/2024
Gelbfish, Gary   5/14/2020                  4,119       15.42     5/14/2024
Lefkowitz, Steven   5/14/2020                  1,236       15.42     5/14/2024
Turner, James Graham   5/18/2020                      824       15.42     5/18/2024
Crandall, Keith   5/22/2020                        88       12.14     5/22/2024
Crandall, Keith   5/22/2020                      438       15.42     5/22/2024
Poulter, Donald   5/29/2020                        88       12.14     5/29/2024
Poulter, Donald   5/29/2020                      438       15.42     5/29/2024
Mitton, Christopher   5/31/2020                        88       12.14     5/31/2024
Mitton, Christopher   5/31/2020                      438       15.42     5/31/2024
Turner, James Graham   10/17/2020                      412       12.14     10/17/2024
Money Market Investment Club of Toledo   10/17/2020                      412       12.14     10/17/2024
Pankhurst, Julie   10/17/2020                  1,030       12.14     10/17/2024
Pankhurst, Stephen   10/17/2020                  1,030       12.14     10/17/2024
Ward, Tim   10/17/2020                  2,059       12.14     10/17/2024
Hobart Ltd   10/17/2020                  3,089       12.14     10/17/2024
Elliott, Michael   10/17/2020                      535       12.14     10/17/2024
Smart, Harald Ernest   10/17/2020                  3,089       12.14     10/17/2024
1204742 Ontario Ltd.   10/17/2020                  3,051       12.14     10/17/2024
Clydagh Ltd   10/17/2020                  4,119       12.14     10/17/2024
Gelbfish, Gary   9/30/2021                59,907       13.35     9/30/2026
Goh, Kim P   9/30/2021                14,977       13.35     9/30/2026
Jones, Tyler Heiden   9/30/2021                14,977       13.35     9/30/2026
Lefkowitz, Steven   9/30/2021                14,977       13.35     9/30/2026
Smart, Harald Ernest   9/30/2021                23,963       13.35     9/30/2026
Thunder Bay Financial ,LLC   9/30/2021                31,406       13.35     9/30/2026
Deyoe, Lane   10/20/2021                44,930       13.35     10/30/2026
Alan D Matthes Revocable Trust   11/17/2021                      996       12.14     12/31/2023
Suntup, Alan   11/17/2021                      621       12.14     12/31/2023
Cantone, Anthony   11/17/2021                  2,184       12.14     12/31/2023

 

 II-6 

 

 

Aerni, Bert   11/17/2021                  1,108       12.14     12/31/2023
Nedbalek, Bobby   11/17/2021                  5,054       12.14     12/31/2023
Cantone Asset Management   11/17/2021                      869       12.14     12/31/2023
Cantone Research Inc   11/17/2021                  3,288       12.14     12/31/2023
Martin, Carol   11/17/2021                      198       12.14     12/31/2023
Rhodes, Carol   11/17/2021                  1,242       12.14     12/31/2023
Ginsberg, Daniel   11/17/2021                      297       12.14     12/31/2023
Souimaniphanh, Daniel   11/17/2021                      343       12.14     12/31/2023
David Goodrich   11/17/2021                      621       12.14     12/31/2023
Benaderet, David H Revocable Trust   11/17/2021                  8,110       12.14     12/31/2023
Reklau, David L   11/17/2021                      396       12.14     12/31/2023
Montieth, David V   11/17/2021                      867       12.14     12/31/2023
Williams, David   11/17/2021                      752       12.14     12/31/2023
Radcliffe, Donald & Kathleen   11/17/2021                      257       12.14     12/31/2023
Simmons, Douglas   11/17/2021                      677       12.14     12/31/2023
Edward H Gross & Suanne P Gross Jtwros   11/17/2021                      297       12.14     12/31/2023
Edward Vander Meulen & Carol Vander Meulen   11/17/2021                  1,049       12.14     12/31/2023
Embry Living Trust   11/17/2021                  2,484       12.14     12/31/2023
Mintz, Gary   11/17/2021                  2,698       12.14     12/31/2023
Cant, Geoffrey   11/17/2021                      396       12.14     12/31/2023
Fish, Hamilton   11/17/2021                      369       12.14     12/31/2023
Kahmann, James & Nicole   11/17/2021                      171       12.14     12/31/2023
Spiess, Jana (original holder Robert Benach deceased)   11/17/2021                  1,980       12.14     12/31/2023
Gaur, Jean   11/17/2021                  1,212       12.14     12/31/2023
Jeffery S & Kimberly L Hinkle Jt Ten   11/17/2021                  1,135       12.14     12/31/2023
Jiyuan, LLC.   11/17/2021                  3,826       12.14     12/31/2023
Collins, Joe   11/17/2021                  1,782       12.14     12/31/2023
Schleyer, John   11/17/2021                      824       12.14     12/31/2023
John T Bloom Jr & Janet G Bloom   11/17/2021                      495       12.14     12/31/2023
Kushner, Jonathan   11/17/2021                      621       12.14     12/31/2023
Stone, Jonathan   11/17/2021                      171       12.14     12/31/2023
Sun, Jordan   11/17/2021                      171       12.14     12/31/2023
Williams, Joyce   11/17/2021                      257       12.14     12/31/2023
Mills, Kenneth   11/17/2021                      248       12.14     12/31/2023
Richardson, Kenneth   11/17/2021                      514       12.14     12/31/2023
Conlin, Kevin   11/17/2021                      171       12.14     12/31/2023
Patel, Manish   11/17/2021                      198       12.14     12/31/2023
Weber, Marc   11/17/2021                      923       12.14     12/31/2023
Noar, Mark   11/17/2021                      857       12.14     12/31/2023
Villafana, Martin   11/17/2021                  2,441       12.14     12/31/2023
Peterson, Melissa   11/17/2021                      798       12.14     12/31/2023
Mayster, Melvin   11/17/2021                      198       12.14     12/31/2023
Krushinsky, Michael   11/17/2021                      198       12.14     12/31/2023
Ciocca, Michelangelo   11/17/2021                      171       12.14     12/31/2023
Langer, Milton   11/17/2021                      668       12.14     12/31/2023
Mitchell R Setzer & Nancy P Setzer Jt Ten   11/17/2021                      505       12.14     12/31/2023
Money Market Investment Club of Toledo   11/17/2021                  1,536       12.14     12/31/2023
Monte and Janet Anglin Revocable Living Trust   11/17/2021                  1,221       12.14     12/31/2023
Bluth, Mordecai   11/17/2021                      428       12.14     12/31/2023
Pat S West & Patricia Kay West   11/17/2021                      198       12.14     12/31/2023
Durward, Jaycee   11/17/2021                      171       12.14     12/31/2023
Patricia Kay West Trust   11/17/2021                      171       12.14     12/31/2023
Dennis, Patrick   11/17/2021                  1,992       12.14     12/31/2023
Ragonese III, Patsy   11/17/2021                  1,306       12.14     12/31/2023
Suntup, Paul   11/17/2021                  1,584       12.14     12/31/2023
Pensco Trust Company LLC Custodian FBO Stuart D Shaymen IRA   11/17/2021                      428       12.14     12/31/2023
Pensco Trust Company LLC Custodian FBO Susan Rodio IRA   11/17/2021                  1,028       12.14     12/31/2023
Peter Coppola and Sharon Coppola   11/17/2021                      990       12.14     12/31/2023
Doremus, Raymond   11/17/2021                      171       12.14     12/31/2023
Rinehart Trust "A" Marlyn W Rinehart Trustee   11/17/2021                      857       12.14     12/31/2023
Neville-Landwher, Rita   11/17/2021                  1,049       12.14     12/31/2023
Robert J Barnell Trust   11/17/2021                      171       12.14     12/31/2023
Robert L Boxer & Susan S Rodio JTWRS   11/17/2021                  1,738       12.14     12/31/2023
Young, Robert M   11/17/2021                  1,242       12.14     12/31/2023
Hunsinger, Rodney & Cheryl   11/17/2021                      257       12.14     12/31/2023
Chiarelli, Santo   11/17/2021                      198       12.14     12/31/2023

 

 II-7 

 

 

Select Global Investments, LLC   11/17/2021                      857       12.14     12/31/2023
Suresh, Sharma   11/17/2021                      248       12.14     12/31/2023
Neal, Sheldon   11/17/2021                  1,847       12.14     12/31/2023
Sneh & Suresh Sharma Living Trust   11/17/2021                      171       12.14     12/31/2023
Stanley E Ginsberg & Arlene D Ginsberg Jt Ten   11/17/2021                      495       12.14     12/31/2023
Polakoff, Stephen   11/17/2021                      621       12.14     12/31/2023
Shayman, Stuart   11/17/2021                      495       12.14     12/31/2023
Rahaim, T. Michael   11/17/2021                  2,285       12.14     12/31/2023
McQuaide, Thomas J   11/17/2021                      297       12.14     12/31/2023
Thomas R Gardner Trust   11/17/2021                      198       12.14     12/31/2023
Thunder Bay Financial ,LLC   11/17/2021                37,253       12.14     12/31/2023
MacRae, Tim   11/17/2021                      839       12.14     12/31/2023
Timothy & Loretta Werkley   11/17/2021                      198       12.14     12/31/2023
Nedbalek, Troy   11/17/2021                  1,043       12.14     12/31/2023
Polakoff, Victor   11/17/2021                  1,242       12.14     12/31/2023
William B Telfair & Carole H Telfair Jt Ten   11/17/2021                  1,036       12.14     12/31/2023
William H Bayer & Linda G Bayer TIC   11/17/2021                      495       12.14     12/31/2023
Waack, William   11/17/2021                      171       12.14     12/31/2023
1204742 Ontario Ltd.   11/17/2021                  2,208       12.14     12/31/2023
156132 Ontario Inc.   11/17/2021                  1,323       12.14     12/31/2023
LaBelle, Carla   11/17/2021                      695       12.14     12/31/2023
Hill, Christopher   11/17/2021                        86       12.14     12/31/2023
Mitton, Christopher   11/17/2021                  1,639       12.14     12/31/2023
Proud, Clifford   11/17/2021                  2,149       12.14     12/31/2023
Clydagh Ltd   11/17/2021                12,457       12.14     12/31/2023
Dossetter, Colin   11/17/2021                      237       12.14     12/31/2023
Taylor, Darren Charles   11/17/2021                  1,179       12.14     12/31/2023
Crandall, Donald   11/17/2021                      365       12.14     12/31/2023
Poulter, Donald   11/17/2021                  3,328       12.14     12/31/2023
Lefkowitz, Steven   11/17/2021                  3,084       12.14     12/31/2023
Eschler Global Fund SPC - Recovery Fund Segregated Portfolio   11/17/2021                  1,028       12.14     12/31/2023
Franco Crupi   11/17/2021                      745       12.14     12/31/2023
Poulter, Frederick L.   11/17/2021                      759       12.14     12/31/2023
Gelbfish, Gary   11/17/2021                10,280       12.14     12/31/2023
Gerald M Casey Trust UAD 05/03/2000   11/17/2021                      343       12.14     12/31/2023
Turner, James Graham   11/17/2021                      870       12.14     12/31/2023
Gundyco ITF Robert J Reukl   11/17/2021                  1,191       12.14     12/31/2023
Smart, Harald Ernest   11/17/2021                24,828       12.14     12/31/2023
Harry Smart Pension Scheme   11/17/2021                  1,612       12.14     12/31/2023
Hobart Ltd   11/17/2021                  5,256       12.14     12/31/2023
Alonzo, James   11/17/2021                      638       12.14     12/31/2023
Taylor, Jeremy David   11/17/2021                      737       12.14     12/31/2023
JL Investments Ltd   11/17/2021                      699       12.14     12/31/2023
Davis, John   11/17/2021                  1,355       12.14     12/31/2023
Pankhurst, Julie   11/17/2021                  3,092       12.14     12/31/2023
Smart, Kathleen   11/17/2021                      887       12.14     12/31/2023
Crandall, Keith   11/17/2021                      365       12.14     12/31/2023
Deamer, Colette and Deamer, Kevin   11/17/2021                      491       12.14     12/31/2023
Sheils, Liam   11/17/2021                      246       12.14     12/31/2023
Poulter, Marica   11/17/2021                  1,713       12.14     12/31/2023
Marlene Kaplanis   11/17/2021                      280       12.14     12/31/2023
Elliott, Michael   11/17/2021                      687       12.14     12/31/2023
Trenchard, Miranda   11/17/2021                  2,686       12.14     12/31/2023
Sheldrake, Norman   11/17/2021                      925       12.14     12/31/2023
Nolan, Pa   11/17/2021                  8,735       12.14     12/31/2023
Panda Bay Estates (1990) Limited   11/17/2021                  2,740       12.14     12/31/2023
Perlin Family Holdings Inc.   11/17/2021                  3,730       12.14     12/31/2023
Quatro Investments Corp   11/17/2021                      543       12.14     12/31/2023
Poulter, Robert   11/17/2021                11,444       12.14     12/31/2023
Warner-Smith, Robin David   11/17/2021                      491       12.14     12/31/2023
Brook, Stephen Harold   11/17/2021                      737       12.14     12/31/2023
Pankhurst, Stephen   11/17/2021                  7,514       12.14     12/31/2023
Ward, Tim   11/17/2021                  4,802       12.14     12/31/2023
Warren Peterson Veterinary Prof Corp   11/17/2021                  1,011       12.14     12/31/2023
Poulter, William   11/17/2021                  8,663       12.14     12/31/2023
Pankhurst, Stephen   7/28/2022                  3,744       13.35     7/28/2027
Pankhurst, Julie   7/28/2022                  3,744       13.35     7/28/2027
Ward, Tim   7/28/2022                  4,584       13.35     7/28/2027
Rallo, Joseph   7/28/2022                18,721       13.35     7/28/2027
Boral, David   7/28/2022                18,721       13.35     7/28/2027

 

Total number of warrants issued in connection with the convertible notes: 597,455.

 

 II-8 

 

   

(c) Stock issuances (common stock and preferred stock) in the last 3 fiscal years ended September 30, 2022:

 

During the year ended September 30, 2021, 1,408,666 convertible preferred stock shares were issued as preferred stock dividends, and 57,423 common shares were issued for interest on notes.

 

During the year ended September 30, 2022, 1,524,786 convertible preferred stock shares were issued as preferred stock dividends, and 42,930 common shares were issued for interest on notes.

 

During the three months ended December 31, 2022, 400,445 convertible preferred stock shares were issued as preferred stock dividends.

 

 II-9 

 

  

The securities issued in each of the above sections (a), (b) and (c) were issued in reliance upon the exemption from the registration requirement of the Securities Act provided by Section 4(a)(2) thereof for transactions not involving a public offering, to the extent an exemption from such registration was required.

 

The recipients of securities in each of these transactions acquired the securities for investment only and not with a view to or for sale in connection with any distribution thereof, and appropriate legends were affixed to the securities issued in these transactions. Each of the recipients of securities in these transactions was either an accredited investor within the meaning of Rule 501 of Regulation D under the Securities Act or had adequate access, through employment, business, or other relationships, to information about the Company.

 

(d) Restricted Stock Units

 

As of December 31, 2022, we had reserved 421,568 shares of our common stock for issuance upon settlement of restricted stock units (“RSU”) granted pursuant to the 2015 Restricted Stock Unit Plan (the “2015 RSU Plan”). The 2015 RSU Plan grants provide that one hundred percent (100%) of each of the RSU grants would vest on one year from the date of grant, provided that the grantee continues as a non-employee director, an eligible employee, consultant or advisor of the Company or its subsidiaries until such date. Unless otherwise determined by the Board, or after the date on which a director is elected to the Board or re-elected to an additional one-year term (the “Award Date”), any RSUs outstanding immediately prior to a change in control, but which are not vested, shall become fully vested upon the occurrence of a change in control. If the Board decides not to nominate a grantee for an additional term as director, unless such decision is for cause, the RSUs vest on the date of the Company’s subsequent annual meeting of stockholders at which directors are elected, provided that the grantee continues being a member of the Board until such date. A grantee is also entitled to be credited with dividend equivalents (the “Dividend Equivalents”) in the form of additional fully vested RSUs on each dividend payment date in respect of which normal cash dividends are paid on the underlying shares.

 

As of December 31, 2022, we granted 421,568 RSUs under the 2015 RSU Plan to certain of our employees and directors, each of which entitles the holder to one share of our common stock upon settlement of the RSU. Such RSUs expired according to their terms.

 

The securities issued in each of the above section (d) transactions were issued in reliance upon the exemption from the registration requirement of the Securities Act provided for by Rule 701 promulgated under the Securities Act, in that the transactions were under compensatory benefit plans and contracts relating to compensation. All recipients either received adequate information about us or had access, through employment or other relationships, to such information.

 

 II-10 

 

 

Item 16. Exhibits and Financial Statement Schedules.

 

(a) Exhibits: Reference is made to the Exhibit Index following the signature pages hereto, which Exhibit Index is hereby incorporated into this Item.

 

(b) Financial Statement Schedules: All schedules are omitted because the required information is inapplicable or the information is presented in the financial statements and the related notes.

 

Item 17. Undertakings.

 

The undersigned registrant hereby undertakes: 

 

  1. To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:

  

  (i) To include any prospectus required by section 10(a)(3) of the Securities Act of 1933;

  

  (ii) To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement; and

 

  (iii) To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement.

  

 

 

 2. For the purposes of determining any liability under the Securities Act of 1933, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

 

  3. To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

 

  4. For the purpose of determining liability under the Securities Act of 1933 to any purchaser, if the registrant is subject to Rule 430C, each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use.

 

  5. For the purposes of determining liability under the Securities Act of 1933 to any purchaser in the initial distributions of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:

 

 II-11 

 

  

  (i) Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;

 

  (ii) Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;

 

  (iii) The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and

 

  (iv) Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.

 

  6. For purposes of determining any liability under the Securities Act of 1933, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b) (1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective.

 

Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers and controlling persons pursuant to the provisions above, or otherwise, we have been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act, and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities, other than the payment by us of expenses incurred or paid by one of our directors, officers, or controlling persons in the successful defense of any action, suit or proceeding, is asserted by one of our directors, officers, or controlling persons in connection with the securities being registered, we will, unless in the opinion of our counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question of whether such indemnification is against public policy as expressed in the Securities Act, and we will be governed by the final adjudication of such issue.

 

 II-12 

 

 

EXHIBIT INDEX 

  

Exhibit No. Description
1.1** Form of Underwriting Agreement.
3.1** Certificate of Incorporation of the Registrant
3.2** Amended and Restated Certificate of Incorporation of the Registrant
3.3** Bylaws of the Registrant
3.4** Certificate of Designation, Preferences and Rights of Series A Preferred Stock
3.5** Certificate of Amendment to the Certificate of Incorporation of MDNA Life Sciences, Inc.
3.6** Certificate of Amendment to the Certificate of Incorporation of MDNA Life Sciences, Inc.
4.1** Form of Common Stock Certificate
4.2** Form of Warrant Agreement
4.3** Form of Warrant Agency Agreement
5.1*** Opinion of Lucosky Brookman LLP
10.2** 2015 Restricted Stock Unit Plan, as amended.
10.3** Form of Securities Purchase Agreement and Form of Stock Purchase Warrant for the Series A Convertible Preferred Stock, dated
10.4** Form of Securities Purchase Agreement dated September 30, 2022 for the 12% Secured Convertible Bridge Notes and 12% Secured Convertible Bridge Warrants
10.5** Form of 12% Secured Convertible Bridge Note
10.6** Form of 12% Secured Convertible Bridge Warrant
10.7** Form of 10% Secured Convertible Note
10.8** Form of 8% Secured Convertible Note
10.9** Employment Agreement with Christopher C. Mitton dated as of January 8, 2016.
10.10** Employment Agreement with Robert Poulter dated as of March 1, 2018
10.11** Lease Agreement dated November 30, 2020
10.12** Lease Agreement dated March 21, 2019
10.13** License and distribution agreement with Laboratory Corporation of America Holdings
10.14** Amendment no. 1 to License and distribution agreement with Laboratory Corporation of America Holdings
10.15** Amendment no. 2 to License and distribution agreement with Laboratory Corporation of America Holdings
10.16** Employment Agreement with Jonathan Mills dated as of December 2, 2022
10.17** Securities Purchase Agreement for the December 2022 12% Secured Convertible Bridge Notes and December 2022 12% Secured Convertible Bridge Warrants
10.18** Form of December 2022 12% Secured Convertible Bridge Note
10.19** Form of December 2022 12% Secured Convertible Bridge Warrant
10.20** Agreement between the Company and Christopher C. Mitton dated as of April 24, 2023 Conversion of Deferred Compensation to Common Stock
21.1** List of Subsidiaries of the Registrant.
23.1** Consent of Rosenberg Rich Baker Berman P.A.
23.2*** Consent of Lucosky Brookman LLP (included in Exhibit 5.1)
24.1** Power of Attorney (included on signature page).
107*** Filing Fee Table

 

*

To be filed by an amendment to this registration statement.
**Previously filed.
***Filed herewith.

 

 II-13 

 

  

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of West Palm Beach, State of Florida, on May 9, 2023.

 

  MDNA LIFE SCIENCES INC.
  /s/ Christopher C. Mitton  
  Name: Christopher C. Mitton
  Title: Chief Executive Officer
  (Principal Executive Officer)

 

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

  

Name   Position    Date
         
/s/ Christopher C. Mitton   Chief Executive Officer and Director
(Principal Executive Officer)		   May 9, 2023
Christopher C. Mitton
         
/s/ Jonathan Mills   Chief Financial Officer
(Principal Financial and Accounting Officer)		   May 9, 2023
Jonathan Mills
         
/s/ Harry Smart   Chairman of the Board, Director   May 9, 2023
Harry Smart
         
/s/ Robert Thayer   Director   May 9, 2023
Robert Thayer
         
/s/ Christopher Hill   Director   May 9, 2023
Christopher Hill

 

 II-14